By analysing the phosphorylation levels of NFkB and ERK1/2, we showed that the FV extract was able to reduce both p-NFkB and p-ERK1/2 levels in IL1β-stimulated colon cancer cells (Figure 4b,c), indicating once again an anti-inflammatory activity of FV components. Here, MAPK3 is linked to malignant colon neoplasm.